US 12,241,849 · Application 17/155,594 · Granted Mar 4, 2025
US 12,241,849
Methods of determining protein or peptide concentration and uses thereof
Estimated expiration
July 28, 2042
15y 327d remaining
Earliest effective filing
Aug 14, 2019
+ 20 years
Aug 14, 2039
PTA +1079d
Jul 28, 2042
No TD
—
Final
Jul 28, 2042
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- January 22, 2021
- Earliest effective filing
- August 14, 2019
- Issue date
- March 4, 2025
- PTA
- +1079 days
- Base expiry (before PTA)
- August 14, 2039
August 14, 2019 + 20 years = August 14, 2039 + 1079 PTA days = July 28, 2042
- Continuation of application PCTUS2019046437, filed Aug 14, 2019
- PRO62/720,607 — Provisional — not used for base term
- PRO62/727,708 — Provisional — not used for base term
- PRO62/727,708 — Provisional — not used for base term
- PRO62/720,607 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/155,594 · US 12,241,849
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,241,849: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12241849Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.